Avior Wealth Management LLC’s holdings in Vertex Pharmaceuticals were worth $1,313,000 at the end of the most recent quarter. Activest Wealth Management bought a new position in shares of Vertex Pharmaceuticals during the 1st quarter worth $25,000. Flaharty Asset Management LLC bought a new position in Vertex Pharmaceuticals during the first quarter worth about $32,000. Equities analysts forecast that Vertex Pharmaceuticals Incorporated will post 15.63 earnings per share for the current fiscal year. Receive News & Ratings for Vertex Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vertex Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.